Cargando…
Advantages of DES over BMS in Preventing the Risk of Myocardial Infarction, Ischemic Stroke, and Mortality in Various Populations
Backgrounds: Previous studies have demonstrated that drug-eluting stents (DESs) are more effective than bare metal stents (BMSs) in reducing the risk of myocardial infarction in the short term, but the long-term preventive benefits for myocardial infarction, ischemic stroke, and mortality are not cl...
Autores principales: | Wu, Pei-Ning, Chen, Jia-Hung, Yang, Chuan-Pin, Hsu, Jason C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820891/ https://www.ncbi.nlm.nih.gov/pubmed/36614825 http://dx.doi.org/10.3390/jcm12010024 |
Ejemplares similares
-
Dapagliflozin: BMS 512148; BMS-512148
Publicado: (2012) -
BMS-986020, a Specific LPA(1) Antagonist, Provides Neuroprotection against Ischemic Stroke in Mice
por: Gaire, Bhakta Prasad, et al.
Publicado: (2020) -
Remote Ischemic Conditioning in Ischemic Stroke and Myocardial Infarction: Similarities and Differences
por: Saccaro, Luigi F., et al.
Publicado: (2021) -
Increase in ticagrelor use over time is associated with lower rates of ischemic stroke following myocardial infarction
por: Henriksson, Robin, et al.
Publicado: (2019) -
Comparison of coronary DES and BMS in octogenarians: A systematic review and meta-analysis
por: Gao, Lei, et al.
Publicado: (2013)